Annual Accounts Receivable
$48.60 K
-$31.80 K-39.55%
31 August 2023
Summary:
Lexaria Bioscience annual accounts receivable is currently $48.60 thousand, with the most recent change of -$31.80 thousand (-39.55%) on 31 August 2023. During the last 3 years, it has risen by +$32.00 thousand (+192.77%). LEXX annual accounts receivable is now -83.29% below its all-time high of $290.90 thousand, reached on 31 October 2012.LEXX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
31 May 2024
Summary:
Lexaria Bioscience quarterly accounts receivable is not available.LEXX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEXX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +192.8% | - |
| 5 y5 years | -56.5% | - |
LEXX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.5% | +192.8% | ||
| 5 y | 5 years | -78.5% | +192.8% | ||
| alltime | all time | -83.3% | +2600.0% |
Lexaria Bioscience Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2023 | $48.60 K(-39.6%) | $48.60 K(0.0%) |
| May 2023 | - | $48.60 K(-29.9%) |
| Feb 2023 | - | $69.30 K(-49.4%) |
| Nov 2022 | - | $137.00 K(+70.4%) |
| Aug 2022 | $80.40 K(+384.3%) | $80.40 K(+56.7%) |
| May 2022 | - | $51.30 K(+170.0%) |
| Feb 2022 | - | $19.00 K(+160.3%) |
| Nov 2021 | - | $7300.00(-56.0%) |
| Aug 2021 | $16.60 K(-92.7%) | $16.60 K(-97.9%) |
| May 2021 | - | $784.90 K(+99.1%) |
| Feb 2021 | - | $394.30 K(>+9900.0%) |
| Nov 2020 | - | $3800.00(-98.3%) |
| Aug 2020 | $226.00 K(+102.3%) | $226.00 K(+42.8%) |
| May 2020 | - | $158.30 K(+6.5%) |
| Feb 2020 | - | $148.60 K(+14.5%) |
| Nov 2019 | - | $129.80 K(+16.2%) |
| Aug 2019 | $111.70 K(-45.4%) | $111.70 K(-9.7%) |
| May 2019 | - | $123.70 K(+24.3%) |
| Feb 2019 | - | $99.50 K(-25.1%) |
| Nov 2018 | - | $132.90 K(-35.0%) |
| Aug 2018 | $204.60 K(>+9900.0%) | $204.60 K(-8.6%) |
| May 2018 | - | $223.90 K(+41.5%) |
| Feb 2018 | - | $158.20 K(+1263.8%) |
| Nov 2017 | - | $11.60 K(+544.4%) |
| Aug 2017 | $1800.00(-82.0%) | $1800.00(-93.2%) |
| May 2017 | - | $26.40 K(+149.1%) |
| Feb 2017 | - | $10.60 K(+6.0%) |
| Nov 2016 | - | $10.00 K(0.0%) |
| Aug 2016 | $10.00 K | $10.00 K(-31.5%) |
| May 2016 | - | $14.60 K(-66.6%) |
| Feb 2016 | - | $43.70 K(+25.6%) |
| Nov 2015 | - | $34.80 K(+61.1%) |
| May 2015 | - | $21.60 K(-38.3%) |
| Feb 2015 | - | $35.00 K(-53.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2014 | - | $75.30 K(-23.7%) |
| Aug 2014 | $74.60 K(+93.8%) | - |
| July 2014 | - | $98.70 K(-1.6%) |
| Apr 2014 | - | $100.30 K(-23.3%) |
| Jan 2014 | - | $130.70 K(+239.5%) |
| Oct 2013 | $38.50 K(-86.8%) | $38.50 K(-74.6%) |
| July 2013 | - | $151.80 K(-9.2%) |
| Apr 2013 | - | $167.20 K(-30.3%) |
| Jan 2013 | - | $239.90 K(-17.5%) |
| Oct 2012 | $290.90 K(+26.0%) | $290.90 K(-41.6%) |
| July 2012 | - | $497.90 K(+256.9%) |
| Apr 2012 | - | $139.50 K(-20.9%) |
| Jan 2012 | - | $176.40 K(-23.6%) |
| Oct 2011 | $230.90 K(+208.3%) | $230.90 K(-0.3%) |
| July 2011 | - | $231.60 K(+35.8%) |
| Apr 2011 | - | $170.50 K(-3.1%) |
| Jan 2011 | - | $175.90 K(+134.8%) |
| Oct 2010 | $74.90 K(+77.5%) | $74.90 K(+30.9%) |
| July 2010 | - | $57.20 K(+187.4%) |
| Apr 2010 | - | $19.90 K(-11.2%) |
| Jan 2010 | - | $22.40 K(-46.9%) |
| Oct 2009 | $42.20 K(+172.3%) | $42.20 K(-53.6%) |
| July 2009 | - | $90.90 K(+143.7%) |
| Apr 2009 | - | $37.30 K(-12.2%) |
| Jan 2009 | - | $42.50 K(+174.2%) |
| Oct 2008 | $15.50 K(-59.5%) | $15.50 K(-86.1%) |
| July 2008 | - | $111.80 K(-30.5%) |
| Apr 2008 | - | $160.90 K(-33.7%) |
| Jan 2008 | - | $242.70 K(+533.7%) |
| Oct 2007 | $38.30 K(+227.4%) | $38.30 K(+10.4%) |
| July 2007 | - | $34.70 K(+230.5%) |
| Apr 2007 | - | $10.50 K(+854.5%) |
| Jan 2007 | - | $1100.00(-90.6%) |
| Oct 2006 | $11.70 K | $11.70 K |
FAQ
- What is Lexaria Bioscience annual accounts receivable?
- What is the all time high annual accounts receivable for Lexaria Bioscience?
- What is the all time high quarterly accounts receivable for Lexaria Bioscience?
What is Lexaria Bioscience annual accounts receivable?
The current annual accounts receivable of LEXX is $48.60 K
What is the all time high annual accounts receivable for Lexaria Bioscience?
Lexaria Bioscience all-time high annual accounts receivable is $290.90 K
What is the all time high quarterly accounts receivable for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly accounts receivable is $784.90 K